HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Kondo Selected Research

peptide F4.2

6/2000Induction of cytotoxic T lymphocytes from peripheral blood of human histocompatibility antigen (HLA)-A31(+) gastric cancer patients by in vitro stimulation with antigenic peptide of signet ring cell carcinoma.
1/2000Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Kondo Research Topics

Disease

24Neoplasms (Cancer)
03/2015 - 01/2000
6Neoplasm Metastasis (Metastasis)
09/2005 - 01/2000
6Carcinoma (Carcinomatosis)
06/2001 - 01/2000
5Adenocarcinoma
03/2015 - 01/2000
4Heart Failure
11/2000 - 04/2000
4Stomach Neoplasms (Stomach Cancer)
10/2000 - 01/2000
3Hemorrhage
08/2018 - 02/2001
3Rheumatoid Arthritis
02/2008 - 03/2001
3Hepatocellular Carcinoma (Hepatoma)
01/2006 - 09/2001
3Carcinogenesis
09/2005 - 01/2001
3Fibrosis (Cirrhosis)
09/2001 - 10/2000
3Lung Neoplasms (Lung Cancer)
04/2001 - 02/2000
2Infections
11/2017 - 09/2008
2Necrosis
12/2016 - 08/2000
2Deglutition Disorders (Dysphagia)
11/2016 - 12/2013
2Neutropenia
04/2014 - 11/2001
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2012 - 10/2003
2Myocardial Infarction
08/2001 - 03/2000
2Endometrial Neoplasms (Endometrial Cancer)
06/2001 - 01/2000
2Amyloid Plaque
06/2001 - 01/2001
2Adenoma (Adenomas)
05/2001 - 01/2001
2Adenocarcinoma of Lung
04/2001 - 03/2001
2Periodontal Diseases (Periodontal Disease)
04/2001 - 04/2001
2Experimental Arthritis
02/2001 - 01/2001
2Synovitis
02/2001 - 01/2001
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2001 - 01/2000
2Alzheimer Disease (Alzheimer's Disease)
01/2001 - 01/2000
2Hypertrophy
10/2000 - 06/2000
2Lymphatic Metastasis
09/2000 - 01/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2000 - 01/2000
2Hypertension (High Blood Pressure)
08/2000 - 06/2000
2Diastolic Heart Failure
08/2000 - 06/2000
2Melanoma (Melanoma, Malignant)
06/2000 - 01/2000
2Signet Ring Cell Carcinoma
06/2000 - 01/2000
2Infarction (Infarctions)
04/2000 - 03/2000
1Narcolepsy
01/2020
1Eosinophilia
01/2020
1Nervous System Diseases (Neurological Disorders)
01/2020
1Idiopathic Hypersomnia
01/2020
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2020
1Cataplexy
01/2020
1Wounds and Injuries (Trauma)
08/2018
1Joint Diseases (Joint Disease)
02/2018
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
02/2018
1Parasitic Diseases (Parasitic Disease)
11/2017
1Colorectal Neoplasms (Colorectal Cancer)
03/2015
1End Stage Liver Disease
12/2014
1Liposarcoma
11/2012
1Malignant Mesothelioma
01/2012

Drug/Important Bio-Agent (IBA)

9Messenger RNA (mRNA)IBA
05/2001 - 06/2000
7Proteins (Proteins, Gene)FDA Link
12/2016 - 01/2000
5GadoliniumIBA
09/2001 - 01/2000
4AntigensIBA
06/2001 - 01/2000
3AntibodiesIBA
04/2014 - 07/2000
3LipopolysaccharidesIBA
04/2011 - 03/2001
3ferumoxides (Feridex)FDA Link
03/2001 - 04/2000
3Dinoprostone (PGE2)FDA Link
02/2001 - 08/2000
3Endothelins (Endothelin)IBA
11/2000 - 06/2000
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2020 - 03/2000
2CytokinesIBA
11/2017 - 02/2001
2Neutralizing AntibodiesIBA
04/2014 - 04/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 01/2006
2AnticoagulantsIBA
06/2004 - 04/2000
2AutoantibodiesIBA
05/2004 - 03/2001
2SaltsIBA
06/2001 - 06/2000
2Interleukin-6 (Interleukin 6)IBA
04/2001 - 01/2001
2Monoclonal AntibodiesIBA
03/2001 - 01/2000
2Protons (Proton)IBA
03/2001 - 02/2001
2Insulin (Novolin)FDA Link
03/2001 - 04/2000
2Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
02/2001 - 01/2001
2Glucose (Dextrose)FDA LinkGeneric
10/2000 - 04/2000
2Indigo Carmine (Indigo Blue)IBA
10/2000 - 08/2000
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2000 - 06/2000
2Angiotensin IIIBA
08/2000 - 06/2000
2peptide F4.2IBA
06/2000 - 01/2000
2Cancer VaccinesIBA
06/2000 - 01/2000
2Peptides (Polypeptides)IBA
06/2000 - 01/2000
2HLA-A31 antigenIBA
06/2000 - 01/2000
2EpitopesIBA
01/2000 - 01/2000
1GlycosphingolipidsIBA
01/2020
1miglustat (Zavesca)FDA Link
01/2020
1OrexinsIBA
01/2020
1CholesterolIBA
01/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2017
1Cetuximab (Erbitux)FDA Link
03/2015
1AmmoniaIBA
12/2014
1telomerase RNA (bTR)IBA
12/2014
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2014
1Formaldehyde (Formol)FDA Link
11/2012
1oil red OIBA
11/2012

Therapy/Procedure

8Therapeutics
03/2015 - 01/2000
2Aftercare (After-Treatment)
01/2020 - 10/2003
2Dentures
11/2016 - 12/2013
2Radiotherapy
12/2000 - 01/2000
2Lymph Node Excision (Lymph Node Dissection)
05/2000 - 01/2000
1Mechanical Ventilators (Ventilator)
08/2018
1Critical Care (Surgical Intensive Care)
08/2018
1Thoracotomy
08/2018
1Massage (Zone Therapy)
02/2018
1Off-Label Use
04/2014